StemRIM

¥111.00As of Sun 8 Nov 2026, 12:00 UTC
TSE:4599Healthcare
Country Japan
PE (Fwd) •••
TSR 7Y CAGR (26.37%)
Div yield —
ROE (28.42%)
Biotechnology
Beta (5Y) 1.20
PE TTM —
TSR TTM (59.93%)
Mkt cap ¥6.958B
ROIC (529.39%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥110
(1.22%)
(84.60%)
Hold 4|3|10|4|7
1Q26
2Q26
3Q26
4Q26
Earnings per share¥
1.34
1.44
1.44
1.41
36.48%
41.14%
28.53%
15.95%
Revenue¥M
583.9
609.5
632.1
638.2
15.25%
17.05%
17.11%
13.41%
Peers (US$44.18M)
Cap (US$)
PE
45.38M
—
43.88M
—
Capital
TTM
5Y
10Y
Leveragex
0.472
—
—
EBIT/Intx
1.097
0.265
0.273
Own earn%
53.31
(1.71)
(8.49)
Sh yield%
29.88
18.55
19.73
Owners
Insiders/Inst%
9.46
57.39
Short interest%
2.84
SBC / revenue%
3.80
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
7
Op margin range%
9–15
$1 testx
—
Incr. ROIC%
21